Winslow Evans & Crocker’s Vanguard Health Care ETF VHT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $237K | Buy |
1,062
+755
| +246% | +$168K | 0.04% | 310 |
|
2020
Q3 | $62K | Hold |
307
| – | – | 0.02% | 429 |
|
2020
Q2 | $59K | Sell |
307
-1
| -0.3% | -$192 | 0.02% | 442 |
|
2020
Q1 | $54K | Buy |
308
+16
| +5% | +$2.81K | 0.02% | 418 |
|
2019
Q4 | $58K | Sell |
292
-20
| -6% | -$3.97K | 0.01% | 480 |
|
2019
Q3 | $54K | Buy |
312
+20
| +7% | +$3.46K | 0.02% | 484 |
|
2019
Q2 | $52K | Sell |
292
-194
| -40% | -$34.5K | 0.01% | 501 |
|
2019
Q1 | $86K | Hold |
486
| – | – | 0.02% | 407 |
|
2018
Q4 | $80K | Sell |
486
-18
| -4% | -$2.96K | 0.03% | 395 |
|
2018
Q3 | $94K | Hold |
504
| – | – | 0.03% | 382 |
|
2018
Q2 | $82K | Buy |
504
+22
| +5% | +$3.58K | 0.03% | 408 |
|
2018
Q1 | $74K | Sell |
482
-2
| -0.4% | -$307 | 0.02% | 407 |
|
2017
Q4 | $74.5K | Sell |
484
-16
| -3% | -$2.46K | 0.02% | 416 |
|
2017
Q3 | $76.1K | Sell |
500
-259
| -34% | -$39.4K | 0.03% | 401 |
|
2017
Q2 | $112K | Sell |
759
-33
| -4% | -$4.85K | 0.03% | 417 |
|
2017
Q1 | $109K | Sell |
792
-366
| -32% | -$50.4K | 0.03% | 399 |
|
2016
Q4 | $147K | Sell |
1,158
-112
| -9% | -$14.2K | 0.05% | 335 |
|
2016
Q3 | $169K | Hold |
1,270
| – | – | 0.05% | 319 |
|
2016
Q2 | $166K | Buy |
1,270
+1
| +0.1% | +$130 | 0.05% | 301 |
|
2016
Q1 | $156K | Buy |
1,269
+203
| +19% | +$25K | 0.05% | 299 |
|
2015
Q4 | $141K | Buy |
1,066
+26
| +3% | +$3.45K | 0.04% | 344 |
|
2015
Q3 | $127K | Buy |
1,040
+100
| +11% | +$12.2K | 0.04% | 350 |
|
2015
Q2 | $131K | Buy |
940
+200
| +27% | +$28K | 0.04% | 372 |
|
2015
Q1 | $100K | Buy |
740
+50
| +7% | +$6.77K | 0.03% | 422 |
|
2014
Q4 | $86.5K | Sell |
690
-120
| -15% | -$15K | 0.02% | 440 |
|
2014
Q3 | $94.6K | Buy |
810
+1
| +0.1% | +$117 | 0.03% | 430 |
|
2014
Q2 | $90.3K | Buy |
809
+54
| +7% | +$6.03K | 0.03% | 386 |
|
2014
Q1 | $80.7K | Buy |
755
+280
| +59% | +$29.9K | 0.03% | 408 |
|
2013
Q4 | $48K | Buy |
+475
| New | +$48K | 0.02% | 520 |
|